JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guzzetta, N. A.
Right arrow Articles by Tosone, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guzzetta, N. A.
Right arrow Articles by Tosone, S. R.
Related Collections
Right arrow Blood
Right arrow Heart
Right arrow Pediatrics

Anesth Analg 2006;103:1131-1138
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000247963.40082.8b


PEDIATRIC ANESTHESIA

Clinical Measures of Heparin’s Effect and Thrombin Inhibitor Levels in Pediatric Patients with Congenital Heart Disease

Nina A. Guzzetta, MD*, Bruce E. Miller, MD*, Kathy Todd, RN, BA, CCRC{dagger}, Fania Szlam, MMSc*, Renee H. Moore, MS{ddagger}, Keith K. Brosius, MD*, Elizabeth C. Wilson, MD*, Anna M. Cohen, MD*, and Steven R. Tosone, MD*

From the *Department of Anesthesiology, Emory University School of Medicine; {dagger}Cardiac Research Department, Children’s Healthcare of Atlanta at Egleston; and {ddagger}Department of Biostatistics, Emory University, Atlanta, Georgia.

Address correspondence and reprint requests to Nina A. Guzzetta, MD, Department of Anesthesiology, Children’s Healthcare of Atlanta at Egleston, 1405 Clifton Road, N.E., Atlanta, GA 30322. Address e-mail to nina_guzzetta{at}emoryhealthcare.org.

In this investigation, we examined the relationship among three thrombin inhibitors, antithrombin III (ATIII), heparin cofactor II (HCII), and {alpha}-2-macroglobulin ({alpha}2M), and several clinical tests of heparin’s effect in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. One hundred eighteen children were stratified into six age groups: <1 mo, 1–3 mo, 3–6 mo, 6–12 mo, 12–24 mo, and >10 yr. Baseline ATIII, HCII, and {alpha}2M values were measured. Baseline celite- and kaolin-activated clotting times (ACT) were also measured and repeated 3 min after a standard heparin dose of 400 U/kg. Differences in ACT values before and after heparin administration and a heparin dose–response relationship were calculated for each patient. Kaolin-activated ACT tests showed less variation after heparin administration than celite-activated tests. In contrast to what has been demonstrated in adults, ATIII showed no positive correlation with the clinical tests of heparin’s effect nor did the other thrombin inhibitors. Additionally, patients <1 mo old had unexpectedly low levels of {alpha}2M accompanying their expected low levels of ATIII and HCII. Our findings raise concerns about the ability of heparin to adequately anticoagulate these neonates during cardiopulmonary bypass and, consequently, challenge the accuracy of ACT prolongation to truly reflect the extent of their anticoagulation.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
M. P. Eaton
Antifibrinolytic Therapy in Surgery for Congenital Heart Disease
Anesth. Analg., April 1, 2008; 106(4): 1087 - 1100.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2006 by the International Anesthesia Research Society.